SCHEMBL17023145

SCHEMBL17023145

COc1cc(OC)c(Cl)c(-c2ccc(OC(=O)Nc3cccnc3)c3ncc(N(C)CCN(C)C)nc23)c1Cl

nearest known ligand 0.62

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
FGFR3 P22607 16/20 0.62
SGMS2 Q8NHU3 1/20 0.38
LMNA P02545 1/20 0.38
FGFR4 P22455 1/20 0.37
NOTUM Q6P988 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1126555 0.88 FGFR3 (0.76) FGFR3
SCHEMBL17023102 0.87 FGFR3 (0.79) FGFR3
SCHEMBL17023058 0.85 FGFR3 (0.79) FGFR3
SCHEMBL17023014 0.84 FGFR3 (0.54) FGFR3SGMS2LMNANOTUM
SCHEMBL17023099 0.84 FGFR3 (0.79) FGFR3
SCHEMBL1126124 0.77 FGFR3 (0.72) FGFR3FGFR4
SCHEMBL1126358 0.77 FGFR3 (1.00) FGFR3
SCHEMBL17023087 0.76 FGFR3 (0.81) FGFR3LMNA
SCHEMBL12678203 0.75 FGFR3 (1.00) FGFR3
SCHEMBL17023093 0.75 FGFR3 (0.55) FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2282995-B1 DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS NOVARTIS AG (CH) 2015-08-26 EP claimed